These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28623448)

  • 61. Clinical outcomes of 849 laryngeal cancers treated in the past 40 years: are we succeeding?
    Nakayama M; Okamoto M; Hayakawa K; Miyamoto S; Ishiyama H; Komori S; Okamoto T; Seino Y; Kano K; Soda I; Sekiguchi A; Kawakami S
    Jpn J Clin Oncol; 2014 Jan; 44(1):57-64. PubMed ID: 24174633
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study.
    Céruse P; Cosmidis A; Belot A; Rabilloud M; Fuchsmann C; Poupart M; Ramade A; Tartas S; Favrel V; Pommier P; Zrounba P; Fayette J
    Anticancer Drugs; 2014 Sep; 25(8):970-5. PubMed ID: 24849707
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Real-world treatment patterns and outcomes in Japanese patients with cervical esophageal cancer.
    Ohno K; Nasu M; Matsui H; Baba Y; Yasuda T; Sakuma J; Ikeda K; Maruo T; Okuda T; Narita N; Kato H; Kawasaki T; Sato H; Tokashiki K; Akisada N; Ishinaga H; Akashi K; Okami K; Murayama K; Yamamoto S; Kumakura Y; Kawada K; Shiotani A; Asakage T
    Esophagus; 2022 Oct; 19(4):576-585. PubMed ID: 35525856
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
    Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
    J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
    Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
    Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Larynx preservation in surgical treatment of cervical esophageal cancer--combined procedure of laryngeal suspension and cricopharyngeal myotomy.
    Shiozaki H; Tsujinaka T; Inoue M; Yano M; Doki Y; Miyaguchi M; Inoue T; Hosokawa K; Monden M
    Dis Esophagus; 2000; 13(3):213-8. PubMed ID: 11206635
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study.
    Li HX; Liu J; Cheng Y; Liu MN; Fang WT; Lv CX
    Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29294022
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma.
    Prades JM; Lallemant B; Garrel R; Reyt E; Righini C; Schmitt T; Remini N; Saban-Roche L; Timoshenko AP; Trombert B; Guerrier B
    Acta Otolaryngol; 2010; 130(1):150-5. PubMed ID: 19449227
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Organ preservation for advanced larynx cancer: A review of chemotherapy and radiation combination strategies.
    Bonomi MR; Blakaj A; Blakaj D
    Oral Oncol; 2018 Nov; 86():301-306. PubMed ID: 30409316
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma.
    Murakami M; Kuroda Y; Nakajima T; Okamoto Y; Mizowaki T; Kusumi F; Hajiro K; Nishimura S; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):277-84. PubMed ID: 10487546
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible?
    Levy A; Blanchard P; Temam S; Maison MM; Janot F; Mirghani H; Bidault F; Guigay J; Lusinchi A; Bourhis J; Daly-Schveitzer N; Tao Y
    Strahlenther Onkol; 2014 Jul; 190(7):654-60. PubMed ID: 24589921
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients.
    Canis M; Martin A; Ihler F; Wolff HA; Kron M; Matthias C; Steiner W
    Head Neck; 2014 Jun; 36(6):859-66. PubMed ID: 23720321
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
    Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Preservation of the larynx in advanced cancer--experiences at the Oncology Department, Rambam Medical Center, Haifa].
    Rosenblatt E; Siegelmann-Danieli N; Zidan J; Haim N; Kuten A
    Harefuah; 2000 Oct; 139(7-8):271-4, 326. PubMed ID: 11062969
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
    Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience.
    Wang S; Liao Z; Chen Y; Chang JY; Jeter M; Guerrero T; Ajani J; Phan A; Swisher S; Allen P; Cox JD; Komaki R
    J Thorac Oncol; 2006 Mar; 1(3):252-9. PubMed ID: 17409865
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chemoselection combined with alternating chemoradiotherapy or surgery for hypopharyngeal cancer.
    Matsuzuka T; Sato H; Suzuki R; Suzuki M; Saijoh S; Ikeda M; Nakaegawa Y; Tani A; Imaizumi M; Matsui T; Nomoto Y; Nomoto M; Tada Y; Suzuki Y; Omori K
    Laryngoscope; 2016 Jun; 126(6):1349-53. PubMed ID: 26536058
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
    Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.